KORU Medical Systems, Inc. (NASDAQ:KRMD) Receives $6.13 Average PT from Analysts

KORU Medical Systems, Inc. (NASDAQ:KRMD) has received a consensus recommendation of “Moderate Buy” from the six ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $6.1250.

Several brokerages have issued reports on KRMD. Canaccord Genuity Group lifted their price objective on KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. Craig Hallum restated a “buy” rating and issued a $7.00 target price on shares of KORU Medical Systems in a research note on Tuesday, January 13th. Weiss Ratings reiterated a “sell (d-)” rating on shares of KORU Medical Systems in a research report on Thursday, January 22nd. Lake Street Capital increased their price objective on shares of KORU Medical Systems from $6.00 to $8.00 and gave the stock a “buy” rating in a report on Monday, December 22nd. Finally, Wall Street Zen upgraded shares of KORU Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Monday, January 12th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Police & Firemen s Retirement System of New Jersey bought a new position in KORU Medical Systems in the 2nd quarter valued at $30,000. BNP Paribas Financial Markets lifted its stake in shares of KORU Medical Systems by 52.1% during the third quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock valued at $39,000 after acquiring an additional 3,478 shares during the period. Lazard Asset Management LLC bought a new position in KORU Medical Systems in the second quarter valued at about $59,000. Acadian Asset Management LLC bought a new position in KORU Medical Systems in the first quarter valued at about $63,000. Finally, Intech Investment Management LLC acquired a new stake in KORU Medical Systems in the second quarter worth about $73,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

KORU Medical Systems Trading Up 1.0%

NASDAQ KRMD opened at $4.92 on Thursday. The stock has a market cap of $227.89 million, a price-to-earnings ratio of -61.50 and a beta of 0.44. The firm’s 50 day moving average price is $5.71 and its two-hundred day moving average price is $4.65. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.92 and a current ratio of 2.48. KORU Medical Systems has a twelve month low of $1.86 and a twelve month high of $6.61.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.